Deleterious effects of β-blockers on exercise capacity and hemodynamics in patients with portopulmonary hypertension

Gastroenterology

Volumn 130, Issue 1, 2006, Pages 120-126

  Provencher, Steeve ^a   Herve, Philippe ^b   Jais, Xavier ^a   Lebrec, Didier ^c   Humbert, Marc ^a   Simonneau, Gerald ^a   Sitbon, Olivier ^a  

^a HÔPITAL ANTOINE BÉCLÈRE   (France)

^b CENTRE CHIRURGICAL MARIE LANNELONGUE   (France)

^c BEAUJON HOSPITAL   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ATENOLOL; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; FUROSEMIDE; PROPRANOLOL; PROSTACYCLIN; SPIRONOLACTONE;

ADULT; ARTICLE; CHRONOTROPISM; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE EXACERBATION; DRUG WITHDRAWAL; ESOPHAGUS VARICES BLEEDING; EXERCISE; EXERCISE TOLERANCE; HEART CATHETERIZATION; HEART OUTPUT; HEART RATE; HEART STROKE VOLUME; HEMODYNAMICS; HUMAN; LUNG ARTERY PRESSURE; PORTAL HYPERTENSION; PRIORITY JOURNAL; PULMONARY HYPERTENSION; VASCULAR RESISTANCE;

EID: 30044440867     PISSN: 00165085     EISSN: None     Source Type: Journal    
DOI: 10.1053/j.gastro.2005.10.013     Document Type: Article

References (24)

1. G. Simonneau, N. Galie, L.J. Rubin, D. Langleben, W. Seeger, G. Domenighetti, S. Gibbs, D. Lebrec, R. Speich, M. Beghetti, S. Rich, A. Fishman Clinical classification of pulmonary hypertension J Am Coll Cardiol 43 2004 5S 12S
2. R. Rodriguez-Roisin, M.J. Krowka, P. Herve, M.B. Fallon ERS Task Force Pulmonary-Hepatic Vascular Disorders (PHD) Scientific Committee Pulmonary-hepatic vascular disorders (PHD) Eur Respir J 24 2004 861 880
3. T. Poynard, P. Cales, L. Pasta, G. Ideo, J.P. Pascal, L. Pagliaro, D. Lebrec Beta-adrenergic-antagonist drugs in the prevention of gastrointestinal bleeding in patients with cirrhosis and esophageal varices. An analysis of data and prognostic factors in 589 patients from four randomized clinical trials. Franco-Italian Multicenter Study Group N Engl J Med 324 1991 1532 1538
4. D. Lebrec Haemodynamic assessment Baillieres Clin Gastroenterol 9 1995 759 769
5. ATS Committee on Proficiency Standards for Clinical Pulmonary Function Laboratories ATS statement guidelines for the six-minute walk test Am J Respir Crit Care Med 166 2002 111 117
6. G.A. Borg Psychophysical bases of perceived exertion Med Sci Sports Exerc 14 1982 377 381
7. D. Chemla, V. Castelain, P. Herve, Y. Lecarpentier, S. Brimioulle Haemodynamic evaluation of pulmonary hypertension Eur Respir J 20 2002 1314 1331
8. O. Sitbon, F. Brenot, A. Denjean, A. Bergeron, F. Parent, R. Azarian, P. Herve, B. Raffestin, G. Simonneau Inhaled nitric oxide as a screening vasodilator agent in primary pulmonary hypertension. A dose-response study and comparison with prostacyclin Am J Respir Crit Care Med 151 1995 384 389
9. R.J. Barst, M. McGoon, A. Torbicki, O. Sitbon, M.J. Krowka, H. Olschewski, S. Gaine Diagnosis and differential assessment of pulmonary arterial hypertension J Am Coll Cardiol 43 2004 40S 47S
10. V. Castelain, D. Chemla, M. Humbert, O. Sitbon, G. Simonneau, Y. Lecarpentier, P. Herve Pulmonary artery pressure-flow relations after prostacyclin in primary pulmonary hypertension Am J Respir Crit Care Med 165 2002 338 340
11. N. Galie, W. Seeger, R. Naeije, G. Simonneau, L.J. Rubin Comparative analysis of clinical trials and evidence-based treatment algorithm in pulmonary arterial hypertension J Am Coll Cardiol 43 2004 81S 88S
12. M.M. Hoeper, M. Halank, C. Marx, G. Hoeffken, H.J. Seyfarth, J. Schauer, J. Niedermeyer, J. Winkler Bosentan therapy for portopulmonary hypertension Eur Respir J 25 2005 502 508
13. M. Johnson The beta-adrenoceptor Am J Respir Crit Care Med 158 1998 S146 S153
14. N.L. McDaniel, C.M. Rembold, R.A. Murphy Cyclic nucleotide dependent relaxation in vascular smooth muscle Can J Physiol Pharmacol 72 1994 1380 1385
15. J.S. Janicki, K.T. Weber, M.J. Likoff, A.P. Fishman The pressure-flow response of the pulmonary circulation in patients with heart failure and pulmonary vascular disease Circulation 72 1985 1270 1278
16. G.E. D'Alonzo, L. Gianotti, D.R. Dantzker Noninvasive assessment of hemodynamic improvement during chronic vasodilator therapy in obliterative pulmonary hypertension Am Rev Respir Dis 133 1986 380 384
17. M. Nootens, C.J. Wolfkiel, E.V. Chomka, S. Rich Understanding right and left ventricular systolic function and interactions at rest and with exercise in primary pulmonary hypertension Am J Cardiol 75 1995 374 377
18. M.S. Riley, J. Porszasz, M.P. Engelen, B.H. Brundage, K. Wasserman Gas exchange responses to continuous incremental cycle ergometry exercise in primary pulmonary hypertension in humans Eur J Appl Physiol 83 2000 63 70
19. G. Deboeck, G. Niset, M. Lamotte, J.-L. Vachiéry, R. Naeije Exercise testing in pulmonary arterial hypertension and in chronic heart failure Eur Respir J 23 2004 747 751
20. S. Provencher, D. Chemla, P. Hervé, O. Sitbon, M. Humbert, G. Simonneau Heart rate responses during the 6-minute walk test in pulmonary arterial hypertension (in press) Am J Respir Crit Care Med 2006
21. D. Lebrec Pharmacologic prevention of variceal bleeding and rebleeding J Hepatol 17 1993 S29 S33
22. S. Velez-Roa, A. Ciarka, B. Najem, J.L. Vachiery, R. Naeije, P. van de Borne Increased sympathetic nerve activity in pulmonary artery hypertension Circulation 110 2004 1308 1312
23. J. Sandoval, J. Gaspar Atrial septostomy A.J. Peacock L.J. Rubin Pulmonary circulation diseases and their treatment 2nd ed. 2004 Arnold London, England 319 333
24. J. Constant A review of why and how we may use beta-blockers in congestive heart failure Chest 113 1998 800 808